Atlas FDA

Elekta Synergy The Elekta Synergy System is intended to be used for radiation therapy treatment of malignant neoplastic

FDA device recall Z-3079-2011 · posted 2011-08-29 · Terminated

Recall details

Recalling firm
Elekta, Inc.
Reason for recall
A small number of the Modular Reverse Diodes (D1A), a component in the equipment room of the Elekta Linear Accelerator, have ruptured.
Action taken
ELEKTA sent an IMPORTANT NOTICE (FCO 20000103022), dated May 6, 2011. The notice identified the product, the problem, and the aciton to be taken by the customer. Elekta recommended that service personnel always wear protective safety glasses, when they do work on the modulator assembly with the covers removed. Elekta also recommended that users make sure that the modulator cover is installed when the digital accelerator is in operation. Elekta will release a Field Change Order when a corrective action is identified.
Root cause
Other
Status
Terminated
Quantity affected
368
Distribution
Nationwide and Puerto Rico
Date initiated
2011-05-06
Date posted
2011-08-29
Date terminated
2012-10-02
Location
Norcross, GA

Monitor recalls programmatically

Recalls and clearances share one API, with change alerts when new recalls post.

Related 510(k) clearances

RecordFirmDate
ELEKTA SYNERGY; ELEKTA SYNERGY S AND XVIR3.5 (K051932)Elekta, Inc.2005-08-12
ELEKTA SYNERGY SYSTEM (K032996)Elekta Oncology Systems, Ltd.2003-10-23
PHILIPS SLI SERIES LINEAR ACCELERATOR (K963624)Philips Medical Systems, Inc.1996-12-06